Published 2005
| Version v1
Miscellaneous
The synthesis of isotopic fluorine and iodine-labeled COX-II inhibitor and in vitro validation
Creators
- 1. Korea Institute of Radiological and Medical Sciences, Seoul (Korea, Republic of)
Description
In these day, NASIDs (non-steroidal antiinflammatory drugs) such as aspirin, diclofenac and ibuprofen are the most common medications used to reduce pain and inflammation. However, they act by inhibiting both COX-I and COX-II which can cause serious gastrointestinal side effects such as ulcers, stomach perforations and bleeds. COX-I produces prostaglandins believed to be responsible for the protection of the stomach lining. However, COX-II produces prostaglandins believed to be responsible for pain and inflammation. Recently, the most widely studied selective COX-II inhibitor such as celecoxib and rofecoxib' one work by inhibiting the effect of COX-II on pain and inflammation without inhibiting COX-I which protects gastrointestinal lining
Additional details
Publishing Information
- Publisher
- KNS
- Imprint Place
- Taejon (Korea, Republic of)
- Imprint Title
- Proceedings of the KNS spring meeting
- Imprint Pagination
- [1 CD-ROM]
- Journal Page Range
- [2 p.]
Conference
- Title
- 2005 spring meeting of the KNS
- Dates
- 26-27 May 2005
- Place
- Jeju (Korea, Republic of)
INIS
- Country of Publication
- Korea, Republic of
- Country of Input or Organization
- Korea, Republic of
- INIS RN
- 37041805
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Conference, Non-conventional Literature
- Descriptors DEI
- FLUORINE ISOTOPES; IN VITRO; RADIOPHARMACEUTICALS; SYNTHESIS; VALIDATION
- Descriptors DEC
- DRUGS; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; RADIOACTIVE MATERIALS; TESTING
Optional Information
- Notes
- 2 refs, 5 figs, 1 tab